dr. K. Meijer

Clinical Chemist

No picture available
E-mail:
kornelis.meijer umcg.nl

Research

  1. 2020
  2. van Es, J., Cheung, Y. W., van Es, N., Klok, F. A., Dronkers, C. E. A., ten Wolde, M., Kruip, M. J. H. A., Huisman, M. V., Meijer, K., Kamphuisen, P. W., Gerdes, V. E. A., & Middeldorp, S. (2020). Short-term prognosis of breakthrough venous thromboembolism in anticoagulated patients. Thrombosis Research, 187, 125-130. https://doi.org/10.1016/j.thromres.2020.01.010
  3. 2019
  4. WiN Study Grp, Atiq, F., Fijnvandraat, K., van Galen, K. P. M., Laros-Van Gorkom, B. A. P., Meijer, K., de Meris, J., Coppens, M., Mauser-Bunschoten, E. P., Cnossen, M. H., van der Bom, J. G., Eikenboom, J., & Leebeek, F. W. G. (2019). BMI is an important determinant of VWF and FVIII levels and bleeding phenotype in patients with von Willebrand disease. American Journal of Hematology, 94(8), E201-E205. https://doi.org/10.1002/ajh.25499
  5. 2017
  6. 2015
  7. 2014
  8. 2011
  9. 2010

ID: 284813